Breaking News Instant updates and real-time market news.

EXAS

Exact Sciences

$18.33

-0.21 (-1.13%)

06:03
10/17/16
10/17
06:03
10/17/16
06:03

Exact Sciences announces Cologuard now covered under TRICARE

Exact Sciences announced that Cologuard is now covered under TRICARE's preventive services policies for use every three years without patient coinsurance, copayments or deductibles. The update was made after TRICARE's review of its screening coverage policies to align them with the preventive services coverage mandate of the Affordable Care Act. TRICARE is the health care program of the U.S. Department of Defense, providing benefits to 9.4M active-duty, reserve and National Guard personnel, veterans and their dependents.

  • 26

    Oct

  • 15

    Nov

  • 17

    Nov

EXAS Exact Sciences
$18.33

-0.21 (-1.13%)

08/10/16
CHLM
08/10/16
NO CHANGE
Target $26
CHLM
Buy
Craig-Hallum positive on HCSC, Florida Blue coverage of Exact Sciences Cologuard
Craig-Hallum analyst Bill Bonello notes that two payors, namely Health Care Service Corporation, or HCSC, and Florida Blue posted updated Medical Policies indicating that Exact Sciences' Cologuard may be "medically necessary" for colorectal cancer screening. The analyst believes this is a "very positive" indicator of how other payors will interpret the positive recommendation from the U.S. Preventive Services Task Force issued in June. Further, he sees Exact Sciences as well positioned to become standard of care for colon cancer screening, which could be a $3B-$5B opportunity over time. Bonello reiterates a Buy rating and $26 price target on the shares.
08/15/16
ADAM
08/15/16
NO CHANGE
Target $24
ADAM
Buy
Exact Sciences price target raised to $24 from $19 at Canaccord
Canaccord analyst Mark Massaro raised his price target on Exact Sciences to $24 from $19 citing expectations of ongoing commercial momentum in the second half of the year coupled with new commercial payor wins. Massaro raised its numbers based on recent payor wins and the belief Q3 guidance feels achievable. Massaro reiterated his Buy rating on Exact Sciences shares.
09/01/16
CHLM
09/01/16
NO CHANGE
Target $26
CHLM
Buy
Exact Sciences Cologuard to receive commercial payor coverage, says Craig-Hallum
After eviCore suggested that Exact Sciences' Cologuard may be considered for colorectal cancer screening once every three years, Craig-Hallum analyst Bill Bonello says he believes that at least one large health insurer, Highmark, has already elected to follow this policy. The analyst continues to believe that Cologuard will receive broad commercial payer coverage in light of the 2016 USPSFT final colorectal cancer screening recommendation and that increased payer coverage will drive increased test volumes. He reiterates a Buy rating and $26 price target on the shares.
10/03/16
CHLM
10/03/16
NO CHANGE
CHLM
Craig-Hallum says to buy Exact Sciences
Craig-Hallum said it would be buyers of Exact Sciences following the inclusion of Colguard in Healthcare Effectiveness Data and Information Set, or HEDIS. The firm's analyst said HEDIS will drive both payor coverage and provider adoption of Cologuard as physicians now have a greater incentive to order Cologuard and payors have an increased incentive to facilitate Cologuard adoption.

TODAY'S FREE FLY STORIES

EHC

Encompass Health

$51.31

-0.15 (-0.29%)

06:11
01/17/18
01/17
06:11
01/17/18
06:11
Initiation
Encompass Health initiated  »

Encompass Health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$176.19

-0.9 (-0.51%)

06:09
01/17/18
01/17
06:09
01/17/18
06:09
Downgrade
Apple rating change  »

Longbow downgrades Apple…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

SPG

Simon Property

$165.04

-0.47 (-0.28%)

, SBUX

Starbucks

$60.56

0.16 (0.26%)

06:09
01/17/18
01/17
06:09
01/17/18
06:09
Periodicals
Simon, Starbucks reach settlement over Teavana closures, WSJ reports »

Simon Property Group…

SPG

Simon Property

$165.04

-0.47 (-0.28%)

SBUX

Starbucks

$60.56

0.16 (0.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 31

    Jan

GOOG

Alphabet

$1,121.76

-0.5 (-0.04%)

, GOOGL

Alphabet Class A

$1,130.70

0.05 (0.00%)

06:08
01/17/18
01/17
06:08
01/17/18
06:08
Hot Stocks
YouTube implements additional requirements for YouTube Partner Program »

In a blog post, Neal…

GOOG

Alphabet

$1,121.76

-0.5 (-0.04%)

GOOGL

Alphabet Class A

$1,130.70

0.05 (0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 23

    Jan

  • 01

    Feb

  • 01

    Feb

  • 07

    Feb

  • 18

    Mar

TPC

Tutor Perini

$27.00

-0.5 (-1.82%)

06:07
01/17/18
01/17
06:07
01/17/18
06:07
Hot Stocks
Tutor Perini subsidiary awarded three new projects for $67M »

Tutor Perini's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORBK

Orbotech

$51.47

0.38 (0.74%)

06:05
01/17/18
01/17
06:05
01/17/18
06:05
Earnings
Orbotech sees FY18 revenue up 12%-14% »

Sees 12-14% revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORBK

Orbotech

$51.47

0.38 (0.74%)

06:04
01/17/18
01/17
06:04
01/17/18
06:04
Earnings
Breaking Earnings news story on Orbotech »

Orbotech sees Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$4.11

-0.14 (-3.29%)

06:03
01/17/18
01/17
06:03
01/17/18
06:03
Hot Stocks
Amarin initiates clinical development of Vascepa in China »

Amarin's partner…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NUVA

NuVasive

$51.99

-1.34 (-2.51%)

06:03
01/17/18
01/17
06:03
01/17/18
06:03
Downgrade
NuVasive rating change  »

Wells Fargo sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$18.21

-0.55 (-2.93%)

06:03
01/17/18
01/17
06:03
01/17/18
06:03
Hot Stocks
GE: Peter Stracar to succeed Mark Hutchinson as President and CEO of GE Europe »

GE announces the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

KL

Kirkland Lake Gold

$16.74

0.62 (3.85%)

06:03
01/17/18
01/17
06:03
01/17/18
06:03
Hot Stocks
Kirkland Lake Gold sees FY18 production growth to over 620,000 ounces »

Highlights of 2018…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORBK

Orbotech

$51.47

0.38 (0.74%)

06:02
01/17/18
01/17
06:02
01/17/18
06:02
Earnings
Orbotech reports preliminary Q4 revenue of about $256M, consensus $250.16M »

Gross margin is expected…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWTR

Twitter

$24.66

-0.75 (-2.95%)

06:01
01/17/18
01/17
06:01
01/17/18
06:01
Periodicals
Twitter sued by TWiT for breach of contract, infringement, TechCrunch reports »

Twitter is being sued by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 23

    Jan

  • 07

    Feb

  • 08

    Feb

SLGN

Silgan Holdings

$29.29

-0.23 (-0.78%)

, CCK

Crown Holdings

$57.79

-0.31 (-0.53%)

05:58
01/17/18
01/17
05:58
01/17/18
05:58
Downgrade
Silgan Holdings, Crown Holdings, Berry Global, Ball Corp. rating change  »

Silgan Holdings…

SLGN

Silgan Holdings

$29.29

-0.23 (-0.78%)

CCK

Crown Holdings

$57.79

-0.31 (-0.53%)

BERY

Berry Global

$59.13

-1.1 (-1.83%)

BLL

Ball Corp.

$38.39

0.49 (1.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

  • 07

    Feb

  • 08

    Feb

ABB

ABB

$28.07

-0.02 (-0.07%)

05:55
01/17/18
01/17
05:55
01/17/18
05:55
Downgrade
ABB rating change  »

ABB downgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

IFF

International Flavors

$152.54

-1.16 (-0.75%)

05:54
01/17/18
01/17
05:54
01/17/18
05:54
Upgrade
International Flavors rating change  »

International Flavors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADNT

Adient

$81.91

-0.51 (-0.62%)

05:54
01/17/18
01/17
05:54
01/17/18
05:54
Downgrade
Adient rating change  »

Adient downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

AEP

American Electric

$67.50

0.04 (0.06%)

05:53
01/17/18
01/17
05:53
01/17/18
05:53
Upgrade
American Electric rating change  »

American Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PPG

PPG

$116.64

-1.53 (-1.29%)

05:53
01/17/18
01/17
05:53
01/17/18
05:53
Downgrade
PPG rating change  »

PPG downgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

NBR

Nabors Industries

$8.23

0.04 (0.49%)

05:52
01/17/18
01/17
05:52
01/17/18
05:52
Downgrade
Nabors Industries rating change  »

Nabors Industries resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

ETH

Ethan Allen

$28.15

-0.5 (-1.75%)

05:52
01/17/18
01/17
05:52
01/17/18
05:52
Downgrade
Ethan Allen rating change  »

Ethan Allen downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

QTS

QTS Realty Trust

$52.47

0.82 (1.59%)

05:50
01/17/18
01/17
05:50
01/17/18
05:50
Downgrade
QTS Realty Trust rating change  »

QTS Realty Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LQ

La Quinta

$18.44

-0.03 (-0.16%)

05:50
01/17/18
01/17
05:50
01/17/18
05:50
Upgrade
La Quinta rating change  »

La Quinta upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASND

Ascendis Pharma

$47.60

1.02 (2.19%)

05:50
01/17/18
01/17
05:50
01/17/18
05:50
Recommendations
Ascendis Pharma analyst commentary  »

Ascendis Pharma price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHLX

Shell Midstream

$30.74

0.21 (0.69%)

05:50
01/17/18
01/17
05:50
01/17/18
05:50
Downgrade
Shell Midstream rating change  »

Shell Midstream…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 22

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.